Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,590.17
(
-0.52%
)
US TECH 100
23,580.80
(
-0.90%
)
Dow Jones
45,987.72
(
-0.51%
)
Brent Oil
107.54
(
0.90%
)
Bitcoin
69,989.48
(
-1.76%
)
News Focus
News Focus
Post# of 257258
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122796
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 88660

Friday, 01/08/2010 10:33:51 AM

Friday, January 08, 2010 10:33:51 AM

Post# of 257258

Boosting in this case isn't simply about QD vs. BID, there is clinical evidence that the resistance barrier is compromised if the PI regimen is not boosted.

I’ve never heard such a claim. If this is true, why does the FDA label for Reyataz include both boosted and non-boosted dosing options?


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today